Recurrent anaphylaxis in the United States: time of onset and risk factors.
Mohamad R ChaabanJared StuartDuncan WatleyGwen BaillargeonYong-Fang KuoPublished in: International forum of allergy & rhinology (2019)
This is the first national study using ICD-10 CM codes looking at rates of biphasic and recurrent anaphylaxis in all patient care settings. Recurrent anaphylaxis is more common in the first 3 days after the initial event, in younger patients (<18 years), and in patients with allergic rhinitis and/or asthma. Physicians need to prescribe epinephrine auto-injectors and educate their patients about the risk of recurrence.